Emergency reversal of anticoagulation with a three-factor prothrombin complex concentrate in patients with intracranial haemorrhage

Blood Transfusion

Volumn 9, Issue 2, 2011, Pages 148-155

  Imberti, Davide ^a   Barillari, Giovanni ^b   Biasioli, Chiara ^c   Bianchi, Marina ^d   Contino, Laura ^e   Duce, Rita ^f   D'Incà, Marco ⁱ   Gnani, Maria Cristina ^a   Mari, Elisa ^g   Ageno, Walter ^h  

^a UNIVERSITY HOSPITAL OF FERRARA   (Italy)

^b SANTA MARIA DELLA MISERICORDIA UNIVERSITY HOSPITAL   (Italy)

^c Civic Hospital   (Italy)

^d VALDUCE HOSPITAL   (Italy)

^e Civic Hospital   (Italy)

^f GALLIERA HOSPITAL   (Italy)

^g S Maria Novella Hospital   (Italy)

^h UNIVERSITY OF INSUBRIA   (Italy)

ⁱ NONE

Author keywords

Intracranial haemorrhage; Oral anticoagulants; Prothrombin complex concentrates

Indexed keywords

ACENOCOUMAROL; PROTHROMBIN COMPLEX; UMAN COMPLEX DI; UNCLASSIFIED DRUG; VITAMIN K GROUP; WARFARIN;

ADULT; AGED; ANTICOAGULATION; ARTICLE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CARDIOMYOPATHY; CAUSE OF DEATH; CLINICAL ARTICLE; CRANIOTOMY; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HEART VALVE; HOSPITALIZATION; HUMAN; MALE; MULTICENTER STUDY; PROSPECTIVE STUDY; THROMBOEMBOLISM; THROMBOSIS; VENOUS THROMBOEMBOLISM;

ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; BLOOD COAGULATION FACTORS; FEMALE; HUMANS; INTERNATIONAL NORMALIZED RATIO; INTRACRANIAL HEMORRHAGES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES;

EID: 79953680507     PISSN: 17232007     EISSN: None     Source Type: Journal    
DOI: 10.2450/2011.0065-10     Document Type: Article

References (40)

1. Ansell J, Hirsh J, Hylek E, et al. Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133: 160S-198S.
2. Palareti G, Leali N, Coccheri S, et al. Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative trial (ISCOAT). Lancet 1996; 348: 423-8. (Pubitemid 26267872)
3. Davis SM, Broderick J, Hennerici M, et al, for the Recombinant Activated Factor VII Intracerebral Hemorrhage Trial Investigators. Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage. Neurology 2006; 66: 1175-81.
4. Nicolini A, Ghirarduzzi A, Iorio A, et al. Intracranial bleeding: epidemiology and relationships with antithrombotic treatment in 241 cerebral hemorrhages in Reggio Emilia. Haematologica 2002; 87: 948-56.
5. Baldi G, Altomonte F, Altomonte M, et al. Intracranial haemorrhage in patients on antithrombotics: clinical presentation and determinants of outcome in a prospective multicentric study in Italian emergency departments. Cerebrovasc Dis 2006; 22: 286-93. (Pubitemid 44338093)
6. Garcia DA, Regan S, Crowther M, Hylek EM. The risk of hemorrhage among patients with warfarin-associated coagulopathy. J Am Coll Cardiol 2006; 47: 804-8. (Pubitemid 43243105)
7. Go AS, Hylek EM, Chang Y, et al. Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice? JAMA 2003; 290: 2685-92.
8. Rosand J, Eckman MH, Knudsen KA, et al. The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhage. Arch Intern Med 2004; 164: 880-4. (Pubitemid 38520629)
9. Aguilar MI, Hart RG, Kase CS, et al. Treatment of warfarin-associated intracerebral hemorrhage: literature review and expert opinion. Mayo Clin Proc 2007; 82: 82-92. (Pubitemid 46036324)
10. Makris M, Greaves M, Phillips W, et al. Emergency oral anticoagulant reversal: the relative efficacy of infusion of fresh frozen plasma and clotting factor concentrate on correction of the coagulopathy. Thromb Haemost 1997; 77: 477-80. (Pubitemid 27121012)
11. Boulis NM, Bobek MP, Schmaier A. Hoff JT. Use of factor IX complex in warfarin-related intracranial hemorrage. Neurosurgery 1999;45:1113-8.
12. Yasaka M, Sakata T, Minematsu K, Naritomi H. Correction of INR by prothrombin complex concentrate and vitamin K in patients with warfarin related hemorrhagic complications. Thromb Res 2002; 108: 25-30. (Pubitemid 36197658)
13. Riess HB, Meier-Hellmann A, Motsch J, et al. Prothrombin complex concentrate (Octaplex) in patients requiring immediate reversal of oral anticoagulation. Thromb Res 2007; 121: 9-16. (Pubitemid 350025993)
14. Lorenz R, Kienast J, Otto U, et al. Successful emergency reversal of phenprocoumon anticoagulation with prothrombin complex concentrate: a prospective clinical study. Blood Coagul Fibrinolysis 2007; 18: 565-70. (Pubitemid 47344305)
15. Leissinger CA, Blatt PM, Hoots WK, Ewenstein B. Role of prothrombin complex concentrates in reversing warfarin anticoagulation: a review of the literature. Am J Hematol 2008; 83: 137-43.
16. Marietta M, Pedrazzi P, Girardis M, Torelli G. Intracerebral haemorrage: an often neglected medical emergency. Intern Emerg Med 2007; 2: 38-45.
17. Yasaka M, Sakata T, Naritomi H, Minematsu K. Optimal dose of prothrombin complex concentrate for acute reversal of oral anticoagulation. Thromb Res 2005; 115: 455-9. (Pubitemid 40409977)
18. Fredriksson K, Norrving B, Stromblad LG. Emergency reversal of anticoagulation after intracerebral hemorrage. Stroke 1992; 23: 972-7.
19. Cartmill M, Dolan G, Byrne JL, Byrne PO. Prothrombin complex concentrate for oral anticoagulant reversal in neurosurgical emergencies. Br J Neurosurg 2000; 14: 458-61.
20. Huttner HB, Schellinger PD, Hartmann M, et al. Hematoma growth and outcome in treated neurocritical care patients with intracerebral hemorrhage related to oral anticoagulant therapy: comparison of acute treatment strategies using vitamin K, fresh frozen plasma, and prothrombin complex concentrates. Stroke 2006; 37: 1465-70. (Pubitemid 44305727)
21. Guidelines of the FCSA. A guide to oral anticoagulant treatment. Haematologica 2003; 88 (suppl.2): 1-47.
22. Baglin TP, Keeling DM, Watson HG. Guidelines on oral anticoagulation (warfarin): third edition - 2005 update. Br J Haematol 2006; 132: 277-85. (Pubitemid 43381534)
23. Steiner T, Kaste M, Forsting M, et al. Recommendations for the management of intracranial haemorrhage - part I: spontaneous intracerebral haemorrhage. The European Stroke Initiative Writing Committee and the Writing Committee for the EUSI Executive Committee. Cerebrovasc Dis 2006; 22: 294-316. (Pubitemid 44338094)
24. Freilone R, Polio B, Delios G, et al. Efficacy and safety of prothrombin complex concentrate (Uman Complex) and vitamin K in a cohort of 56 patients with anticoagulation-related acute intracranial haemorrage: clinical features and outcomes at three months. Haematologica 2009; 94(s4): 114-5.
25. Tiraferri E, Galletti M, Argento A. Emergency use of propthrombin complex concentrates in oral anticoagulant therapy. Rapid reversal. Haematologica 2004; 89: 177.
26. Van Aart L, Eijkhout HW, Kamphuis JS, et al. Individualized dosing regimen for prothrombin complex concentrate more effective than standard treatment in the reversal of oral anticoagulant therapy: an open, prospective randomized controlled trial. Thromb Res 2007; 119: 15-6.
27. Imberti D, Barillari G, Biasioli C, et al. Prothrombin complex concentrates for urgent anticoagulation reversal in patients with intracranial haemorrhage. Pathophysiol Haemost Thromb 2009; 36: 259-65.
28. Evans G, Luddington R. BaglinT. Beriplex P/N reverses severe warfarin induced overcoagulation immediately and completely in patients presenting with major bleeding. Br J Haematol 2001; 115: 998-1001. (Pubitemid 34042922)
29. Preston FE, Laidlaw ST, Sampson B, Kitchen S. Rapid reversal of oral anticogulation with warfarin by a prothrombin complex concentrate (Beriplex): efficacy and safety in 42 patients. Br J Haematol 2002; 116: 619-24. (Pubitemid 34178663)
30. Lankiewicz MW, Hays J, Friedman KD, et al. Urgent reversal of warfarin with prothrombin complex concentrate. J Thromb Haemost 2006; 4: 967-70.
31. Pabinger I, Brenner B, Kalina U, et al. Beriplex P/N Anticoagulation Reversal Study Group. Prothrombin complex concentrate (Beriplex P/N) for emergency anticoagulation reversal: a prospective multinational clinical trial. J Thromb Haemost 2008; 6: 622-31. (Pubitemid 351404929)
32. Viguè M, Ract C, Tremey B, et al. Ultra-rapid management of oral anticoagulant therapy-related surgical intracranial haemorrhage. Intensive Care Med 2007; 33: 721-5. (Pubitemid 46474890)
33. Kessler CM. Urgent reversal of warfarin with prothrombin complex concentrate: where are the evidence-base data? J Thromb Haemost 2006; 4: 963-6.
34. Sorensen B, Johansen P, Nielsen GL, et al. Reversal of the International Normalized Ratio with recombinant activated factor VII in central nervous system bleeding during warfarin thromboprophylaxis: clinical and biochemical aspects. Blood Coagul Fibrinolysis 2003; 14: 469-77. (Pubitemid 36951864)
35. Freeman WD, Brott TG, Barrett KM, et al. Recombinant factor VIIa for rapid reversal of warfarin anticoagulation in acute intracranial hemorrhage. Mayo Clin Proc 2004; 7: 1495-500. (Pubitemid 39578872)
36. Brody DL, Aiyagari V, Shackeford AM, Diringer MN. Use of recombinant factor VIIa in patients with warfarin-associated intracranial hemorrhage. Neurocrit Care 2005; 2: 263-7. (Pubitemid 41112397)
37. Dickneite G. Prothrombin complex concentrate versus recombinant factor VIIa for reversal of coumarin anticoagulation. Thromb Res 2007; 119: 643-51. (Pubitemid 46321505)
38. Tanaka KA, Szlam F, Dickneite G, Levy JH. Effects of prothrombin complex concentrate and recombinant activated factor VII on vitamin K antagonist induced anticoagulation. Thromb Res 2008; 122: 117-23. (Pubitemid 351601847)
39. Franchini M, Lippi G. Prothrombin complex concentrates: an update.Blood Transfus 2010;8:149-54.
40. Appelboam R, Thomas EO. The headache over warfarin in British neurosurgical intensive care units: a national survey of current practice. Intensive Care Med 2007; 33: 1946-53. (Pubitemid 47632259)